Global Pharmaceutical Corporation Gains Cross‑Country Patient Insights

A client working with a global pharmaceutical corporation needed reliable, comparable patient-reported data about opioid‑induced constipation across six countries in North America and Western/Northern Europe. The challenge was to recruit and survey a sensitive patient population (chronic pain patients on opioid therapy) across multiple languages and markets, localize medication lists and wording for each country, coordinate simultaneous fieldwork across time zones, and deliver analyzed results on a tight timeline so the client could act on the findings.

SIS delivered an end‑to‑end multi‑country online research solution: we programmed and hosted a 20‑minute online questionnaire, implemented translated overlays in four languages, localized medication lists per market, managed simultaneous fieldwork across six countries with project managers in two offices (covering multiple time zones), and performed cross‑tabulations and data analysis. Our global project management and localized survey execution ensured consistent data collection and rapid communication with the client throughout fieldwork.

Completed a 500-patient, six-country study with fieldwork in 3 weeks and analysis delivered 1 week later.

1. Sample: 500 patients across 6 countries
2. Fieldwork: completed within 3 weeks
3. Analysis & presentation: delivered in 1 week
4. Demographics: 55% female; 55% aged 45+
5. Geography: higher response rates in Canada, the USA and the UK
6. Clinical: 44% reported ongoing (non-cancer) pain for 1–5 years; 60% reported pain levels of 7–10 on a 1–10 scale

Credibility: The client used the findings to inform meaningful change and development across markets.

FAQ

1. How quickly were results delivered? Fieldwork finished in 3 weeks; analysis and presentation were delivered 1 week after fieldwork completion.
2. What was the ROI? ROI was not reported in the source data.
3. Was the method scalable or replicable? Yes — executed across 6 countries with 500 respondents, demonstrating cross-country scalability.